Table 1.
Main features of patients with and without parvovirus B19 in bronchoalveolar lavage specimens.
| Characteristics | Total | Parvovirus B19 |
||
|---|---|---|---|---|
| N (%) | N+ (%) | N− (%) | P-value | |
| Patient | ||||
| Total | 189 | 7 (3.7%) | 182 (96.25%) | – |
| Male | 121 (64.0%) | 4 (57.1%) | 117 (64.3%) | NS |
| Female | 68 (36.0%) | 3 (42.9%) | 65 (35.7%) | |
| Mean age | 57.8 ± 15.9 (16–84) | 62.0 ± 14.9 (38–78) | 57.8 ± 16.2 (16–84) | NS |
| Immune status | ||||
| Competent | 65 (34.4%) | 3 (42.9%) | 62 (34.1%) | NS |
| Compromised | 124 (65.6%) | 4 (57.1%) | 120 (65.9%) | |
| Transplant | 63 | 2 (28.6.2%) | 61 (33.6%) | |
| SOT | 54 | 2 (3.7%; lung) | 52 (96.3%) | NS |
| BMT | 9 | 0 | 9 (100%) | |
| Non-transplant | 126 | 5 (71.4%) | 121 (66.4%) | |
| Admission to ICU | 24 (15.0%) | 3 (12.5%) | 21 (87.5%) | NS |
| Mortality within 28 days | 21 (13.1%) | 3 (14.3%) | 18 (85.7%) | <0.05 |
| Haematological condition | 40 (21.2%) | 2 (5.0%) | 38 (95.0%) | NS |
| Seasonality | 264 specimens | |||
| Spring + summer | 81 | 0 | 81 (100%) | NS |
| Autumn + winter | 183 | 7 (4.1%) | 139 (95.9%) | |
SOT, solid organ transplant; BMT, bone marrow transplant; ICU, intensive care unit.